Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Shirasaka

Showing results (31-40 of 148) with videos related to

Pageof 15
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 4, 2001
[New oral anticancer drug, TS-1 (S-1)--from bench to clinic]T Shirasaka, M Tsukuda, Y Inuyama, et al.
Japanese Journal of Cancer Research : Gann|July 1, 1987
Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extractsK Tatsumi, M Fukushima, T Shirasaka, et al.
Biochimica Et Biophysica Acta|August 16, 1972
Studies on a reciprocal relationship between nucleoside kinases and 5'-nucleotidaseT Arima, T Shirasaka, H Okuda, et al.
Masui. the Japanese Journal of Anesthesiology|October 6, 1997
[Intravenous neostigmine enhances the analgesic effect of epidural anesthesia]T Shirasaka, Y Suzuki, Y Ono, et al.
Arukoru Kenkyu to Yakubutsu Izon = Japanese Journal of Alcohol Studies & Drug Dependence|September 1, 1985
[CSF neurochemical alterations during alcohol withdrawal]T Saito, F Tsuchiya, H Ishizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
5-Fluorouracil prodrug: role of anabolic and catabolic pathway modulation in therapy of colorectal cancerS Cao, C Frank, T Shirasaka, et al.
Antiviral Research|September 1, 1995
In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddIS Chokekijchai, T Shirasaka, J N Weinstein, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2000
[Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU]T Shirasaka, S Yamamitsu, A Tsuji, et al.
Journal of the Autonomic Nervous System|July 21, 1999
Participation of arterial baroreceptors input and peripheral vasopressin in the suppression of renal sympathetic nerve activity induced by central salt loading in conscious ratsK Kato, T Shirasaka, T Kunitake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1991
[Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil]T Shirasaka, Y Shimamoto, H Ohshimo, et al.
Pageof 15

Showing results (31-40 of 148) with videos related to

Sort By:
Pageof 15
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 4, 2001
[New oral anticancer drug, TS-1 (S-1)--from bench to clinic]T Shirasaka, M Tsukuda, Y Inuyama, et al.
Japanese Journal of Cancer Research : Gann|July 1, 1987
Inhibitory effects of pyrimidine, barbituric acid and pyridine derivatives on 5-fluorouracil degradation in rat liver extractsK Tatsumi, M Fukushima, T Shirasaka, et al.
Biochimica Et Biophysica Acta|August 16, 1972
Studies on a reciprocal relationship between nucleoside kinases and 5'-nucleotidaseT Arima, T Shirasaka, H Okuda, et al.
Masui. the Japanese Journal of Anesthesiology|October 6, 1997
[Intravenous neostigmine enhances the analgesic effect of epidural anesthesia]T Shirasaka, Y Suzuki, Y Ono, et al.
Arukoru Kenkyu to Yakubutsu Izon = Japanese Journal of Alcohol Studies & Drug Dependence|September 1, 1985
[CSF neurochemical alterations during alcohol withdrawal]T Saito, F Tsuchiya, H Ishizawa, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
5-Fluorouracil prodrug: role of anabolic and catabolic pathway modulation in therapy of colorectal cancerS Cao, C Frank, T Shirasaka, et al.
Antiviral Research|September 1, 1995
In vitro anti-HIV-1 activity of HIV protease inhibitor KNI-272 in resting and activated cells: implications for its combined use with AZT or ddIS Chokekijchai, T Shirasaka, J N Weinstein, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|July 18, 2000
[Conceptual changes in cancer chemotherapy--biochemical modulation of 5-FU]T Shirasaka, S Yamamitsu, A Tsuji, et al.
Journal of the Autonomic Nervous System|July 21, 1999
Participation of arterial baroreceptors input and peripheral vasopressin in the suppression of renal sympathetic nerve activity induced by central salt loading in conscious ratsK Kato, T Shirasaka, T Kunitake, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 1, 1991
[Mechanism for synergistic antitumor effect in the combination of 5-fluorouracil with cisplatin in vivo tumor models: from the view of biochemical modulation of 5-fluorouracil]T Shirasaka, Y Shimamoto, H Ohshimo, et al.
Pageof 15